For Brand Drugs, Doom And Gloom In 2010
This article was originally published in The Pink Sheet Daily
Executive Summary
With sluggish pharmaceutical sales growth due to generic uptake, fewer patient visits to doctors and less use of chronic medications - 2010 was a dismal year for brand drugs, IMS data show.